Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Memantine to be tested in AIDS-related dementia, painful peripheral neuropathies

May 17, 1996

SB-221420 in development for stroke

May 17, 1996

SB-238592: Antiinflammatory neuroprotectant in clinical phase

May 17, 1996

Seven new uses for raloxifene appear in patent literature

May 17, 1996

NMDA antagonists reported by Pfizer

May 17, 1996

Valproate effective in dementia patients

May 17, 1996

Increased platelet aggregation in AD patients

May 17, 1996

Sankyo claims allosteric muscarinic effectors for AD

May 17, 1996

GP-3269 on track for clinical testing

May 17, 1996

SB-204269 in phase I for epilepsy

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...